Literature DB >> 28929293

Predictive Biomarkers for Asthma Therapy.

Sarah K Medrek1, Amit D Parulekar2, Nicola A Hanania3.   

Abstract

PURPOSE OF REVIEW: Asthma is a heterogeneous disease characterized by multiple phenotypes. Treatment of patients with severe disease can be challenging. Predictive biomarkers are measurable characteristics that reflect the underlying pathophysiology of asthma and can identify patients that are likely to respond to a given therapy. This review discusses current knowledge regarding predictive biomarkers in asthma. RECENT
FINDINGS: Recent trials evaluating biologic therapies targeting IgE, IL-5, IL-13, and IL-4 have utilized predictive biomarkers to identify patients who might benefit from treatment. Other work has suggested that using composite biomarkers may offer enhanced predictive capabilities in tailoring asthma therapy. Multiple biomarkers including sputum eosinophil count, blood eosinophil count, fractional concentration of nitric oxide in exhaled breath (FeNO), and serum periostin have been used to identify which patients will respond to targeted asthma medications. Further work is needed to integrate predictive biomarkers into clinical practice.

Entities:  

Keywords:  Asthma; Biologics; Biomarkers; Endotypes; Phenotypes; Therapy

Mesh:

Substances:

Year:  2017        PMID: 28929293     DOI: 10.1007/s11882-017-0739-5

Source DB:  PubMed          Journal:  Curr Allergy Asthma Rep        ISSN: 1529-7322            Impact factor:   4.806


  109 in total

Review 1.  Biomarkers and surrogate endpoints: preferred definitions and conceptual framework.

Authors: 
Journal:  Clin Pharmacol Ther       Date:  2001-03       Impact factor: 6.875

2.  T-helper type 2-driven inflammation defines major subphenotypes of asthma.

Authors:  Prescott G Woodruff; Barmak Modrek; David F Choy; Guiquan Jia; Alexander R Abbas; Almut Ellwanger; Laura L Koth; Joseph R Arron; John V Fahy
Journal:  Am J Respir Crit Care Med       Date:  2009-05-29       Impact factor: 21.405

3.  T(H)17-associated cytokines (IL-17A and IL-17F) in severe asthma.

Authors:  Wisam Al-Ramli; David Préfontaine; Fazila Chouiali; James G Martin; Ron Olivenstein; Catherine Lemière; Qutayba Hamid
Journal:  J Allergy Clin Immunol       Date:  2009-04-10       Impact factor: 10.793

4.  Randomized, double-blind, placebo-controlled study of brodalumab, a human anti-IL-17 receptor monoclonal antibody, in moderate to severe asthma.

Authors:  William W Busse; Stephen Holgate; Edward Kerwin; Yun Chon; Jingyuan Feng; Joseph Lin; Shao-Lee Lin
Journal:  Am J Respir Crit Care Med       Date:  2013-12-01       Impact factor: 21.405

5.  MicroRNA Profiling in Asthma: Potential Biomarkers and Therapeutic Targets.

Authors:  Enrico Heffler; Alessandro Allegra; Giovanni Pioggia; Giuseppe Picardi; Caterina Musolino; Sebastiano Gangemi
Journal:  Am J Respir Cell Mol Biol       Date:  2017-12       Impact factor: 6.914

6.  Longitudinal variation of serum periostin levels in adults with stable asthma.

Authors:  Ruth Semprini; Rachel Caswell-Smith; James Fingleton; Cecile Holweg; John Matthews; Mark Weatherall; Richard Beasley; Irene Braithwaite
Journal:  J Allergy Clin Immunol       Date:  2017-01-16       Impact factor: 10.793

7.  Inflammatory subtypes in asthma: assessment and identification using induced sputum.

Authors:  Jodie L Simpson; Rodney Scott; Michael J Boyle; Peter G Gibson
Journal:  Respirology       Date:  2006-01       Impact factor: 6.424

8.  Relationship between urinary cysteinyl leukotriene E4 levels and clinical response to antileukotriene treatment in patients with asthma.

Authors:  Chang Cai; Jiong Yang; Suping Hu; Meiqian Zhou; Wei Guo
Journal:  Lung       Date:  2007-03-28       Impact factor: 2.584

Review 9.  Clinical utility of asthma biomarkers: from bench to bedside.

Authors:  Susanne Jh Vijverberg; Bart Hilvering; Jan Am Raaijmakers; Jan-Willem J Lammers; Anke-Hilse Maitland-van der Zee; Leo Koenderman
Journal:  Biologics       Date:  2013-08-29

10.  Oral glucocorticoid-sparing effect of mepolizumab in eosinophilic asthma.

Authors:  Elisabeth H Bel; Sally E Wenzel; Philip J Thompson; Charlene M Prazma; Oliver N Keene; Steven W Yancey; Hector G Ortega; Ian D Pavord
Journal:  N Engl J Med       Date:  2014-09-08       Impact factor: 91.245

View more
  18 in total

1.  [Levels of airway inflammatory mediators in peripheral blood in infants and young children with wheezing].

Authors:  Xiao-He Yu; Miao He; Xiang-Rong Zheng; Xia Wang; Jian Kuang
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2019-09

Review 2.  Biomarkers of Bronchial Asthma.

Authors:  P Kunc; J Fabry; M Lucanska; R Pecova
Journal:  Physiol Res       Date:  2020-03-27       Impact factor: 1.881

3.  Nasal DNA methylation differentiates severe from non-severe asthma in African-American children.

Authors:  Tao Zhu; Xue Zhang; Xiaoting Chen; Anthony P Brown; Matthew T Weirauch; Theresa W Guilbert; Gurjit K Khurana Hershey; Jocelyn M Biagini; Hong Ji
Journal:  Allergy       Date:  2020-11-25       Impact factor: 13.146

Review 4.  CRTH2 antagonists in asthma: current perspectives.

Authors:  Dave Singh; Arjun Ravi; Thomas Southworth
Journal:  Clin Pharmacol       Date:  2017-12-15

5.  PI3K, p38 and JAK/STAT signalling in bronchial tissue from patients with asthma following allergen challenge.

Authors:  Thomas Southworth; Sarah Mason; Alan Bell; Isabel Ramis; Marta Calbet; Anna Domenech; Neus Prats; Montserrat Miralpeix; Dave Singh
Journal:  Biomark Res       Date:  2018-04-11

Review 6.  Measuring inflammation in paediatric severe asthma: biomarkers in clinical practice.

Authors:  Amelia Licari; Sara Manti; Riccardo Castagnoli; Salvatore Leonardi; Gian Luigi Marseglia
Journal:  Breathe (Sheff)       Date:  2020-03

7.  Approaches to the assessment of severe asthma: barriers and strategies.

Authors:  Eleanor C Majellano; Vanessa L Clark; Natasha A Winter; Peter G Gibson; Vanessa M McDonald
Journal:  J Asthma Allergy       Date:  2019-08-23

8.  Clinical Utility Of The Exhaled Nitric Oxide (NO) Measurement With Portable Devices In The Management Of Allergic Airway Inflammation And Asthma.

Authors:  Sy Duong-Quy
Journal:  J Asthma Allergy       Date:  2019-10-07

9.  Biomarkers of Type 2 Airway Inflammation as Predictors of Loss of Asthma Control During Step-Down Therapy for Well-Controlled Disease: The Long-Acting Beta-Agonist Step-Down Study (LASST).

Authors:  Sonali Bose; Christian Bime; Robert J Henderson; Kathryn V Blake; Mario Castro; Emily DiMango; Nicola A Hanania; Janet T Holbrook; Charles G Irvin; Monica Kraft; Stephen P Peters; Joan Reibman; Elizabeth A Sugar; Kaharu Sumino; Robert A Wise; Linda Rogers
Journal:  J Allergy Clin Immunol Pract       Date:  2020-07-18

10.  Bifidobacterium breve MRx0004 protects against airway inflammation in a severe asthma model by suppressing both neutrophil and eosinophil lung infiltration.

Authors:  Emma J Raftis; Margaret I Delday; Philip Cowie; Seánín M McCluskey; Mark D Singh; Anna Ettorre; Imke E Mulder
Journal:  Sci Rep       Date:  2018-08-13       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.